Replies to post #5293 on Regen BioPharma Inc (RGBP)

[cvinvestor]

That is to be expected. The chances of first round submission approval should not be planned on, but a 50% drop without news means the "strong hands" behind the scenes don't appear very strong. Interesting that those previously telling us so many positive developments were about to come to light have also gone silent and absent.

I just hope the PR on ebola isn't a sign that both HemaX and dCellVax are basically DOA due to things we do not know. We haven't even gotten news on their submission for safety protocol testing proposal and whether it is even going to be done, let alone approval for HemaX.